RIM
SGMO

Rockbridge Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Rockbridge Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-905
Closed -$3.75K – 500
2022
Q2 		$3.75K Hold
905
– – ﹤0.01% 490
2022
Q1 		$5.47K Hold
905
– – ﹤0.01% 610
2021
Q4 		$7K Hold
905
– – ﹤0.01% 620
2021
Q3 		$8K Sell
905
-60
-6% -$593 ﹤0.01% 554
2021
Q2 		$12K Hold
965
– – ﹤0.01% 505
2021
Q1 		$12K Hold
965
– – ﹤0.01% 487
2020
Q4 		$15K Buy
965
+60
+7% +$703 ﹤0.01% 456
2020
Q3 		$9K Hold
905
– – ﹤0.01% 479
2020
Q2 		$8K Buy
+905
New +$8.4K ﹤0.01% 456

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Rockbridge Investment Management's SGMO Position: Q3 2022 in Review

Rockbridge Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2022, closing a stake of 905 shares — an estimated $3.75K sold.

Rockbridge Investment Management first reported a position in SGMO in Q2 2020 and held it in 9 quarters. The position peaked at $15K in Q4 2020. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.

  • Rockbridge Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • Rockbridge Investment Management sold 905 SANGAMO THERAPEUTICS INC shares in Q3 2022, an estimated $3.75K.
  • Rockbridge Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 9 quarters.
  • Rockbridge Investment Management's SANGAMO THERAPEUTICS INC position peaked at $15K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.

Based on Rockbridge Investment Management's 13F filing for Q3 2022, filed 28 May 2024.